Download as pdf
Download as pdf
You are on page 1of 13
KPATKA XAPAKTEPHCTHKA HA IIPOLYKTA, 1, HME HA JIEKAPCTBEHHA IPOAYKT VSMBMHUTENHA ATEHUMR 110 NEKAPCTBATA Roma tapanrepcmura va Reognara Toaaware 7 oh ONT.LG, Oxchxogon Axrapie 20 mg reepan Kaneyzni 3 11-09 200 Oxycodone Actavis 20 mg hard capsules E7888 -F 1 sia mm : Oxcnkonon Axrasnc 10 mg Texpan Kanicy.aH Oxycodone Actavis 10 mg hard capsules t- 2, KAMECTBEH H KOJIMYECTBEH CbCTAB Benxa kaneyaa cemeprka 10 mg un 20 mg oxeHkosoHoe xnApoxstopia (oxycodone hydrochloride), exBHBANENTHH CLOTBETHO Ha 8,96 mg urn 17,93 mg oxcKoRoH (oxycodone). 3a Manus cnucex Ha NOMOUIHHTe BeUlecTBA BIEATE TOUKA 6.1. 3. JEKAPCTBEHA ®OPMA Teepaa kancyna ‘Oxcikoaon Axrasuc 10 mg Tepan KancysH Tenpaw xancys, ¢ anna 14,4 mm, ¢ 630 Tao, Mapkupano c "10" H Kadsa KanlaHKa, Mapxnpana c "OXY", ‘OxcikoaoH Axrasnc 20 mg Tappa kancys ‘Teepan Kancyan, c muxnna 14,4 mm, che cBETTOPOIOBO TANO, MapKKpaHO c "20" H KadaBa KANAYKA, Mapxnpana c "OXY", 4. KJIHHWYHH JAHRE 4.1 Tepanestwain noxasam Ciuna Gonka, KoaTo Monke 1a 6LAe AneKBATHO KyNHpaNa caMo ¢ ONHOHAHM ananreTuU. 42 Josuposka # nagun na npuaoxKenne osuposs Tlosara sanicn oT wiTensHaHocTra Ha GoAKaTa M MHAMBHIYATHaTA MYBCTBMTENHOCT Ha NAMMEHTa KUM nevennero. [Ipunarar ce cnenitre oSum mpenopsxn 2a xosMpane: Brapacmmu u jonouas nad 12-2odmuna amapac Hawawa donposca Karo uano, navaniara 2038 38 NauMeHTH, KOHTO 10 MOMeHTa He ca JeKyBAHH ¢ onHOMAN eS mg, OxcHKOON XAPOXOPHA, NpHTOAeH Ha MHTepsanM OT 6 aca. TIpH NaUIMEHTHTe, KONTO BeHE ony¥asaT ONMOHAH AeYEHHETO MOXE Ha 3ANOYHE C MO-BHCOKM OAM, KATO Ce MMA NpeABHI o OT npeaMuniiTe Tepanin ¢ onHOHaN, Apentara nosa wa naunterrraTe, KOMTO NpenM Tepans c OKCHKOLON BENE pHEMT MopAIA nepopaso, TpaGxa sa ce ocHosaa Ha cieaHoTo cboTHouleHHe: 10 mg OKCHKOAOH nepopa 'SEIH/1226/001-0031A028 expupanenten Ha 20 mg Mopd¥H nepopantio. TpaGea na ce oTGeremH, He TOBA € PLKOBOAHO NpABHAO 3a HeoGXoAMMATa 03a OKCHKONOH XMAPOXAOpHA Kancy.H. HiTTepHHAMBHAyAnHaTa sapHAbWLAHOCT pH naUHeHTHTe HOHCKBA BCeKH NaUHeHT Aa ce THTpHpa BHUMATENHO 20 HEOOXOAMMATA 1032. Adanmupane na doxama acunpamara ce Gonka we H3HcKBA NOBHUNABAHE Ha nOsATa Ha OxcHKOAOH AKTABHC. 3a Ala ce nocturne oGexGoasane, 203aTa Tpa6Ba Aa ce THTPHpA BHHMATeAHO, NP HeOGXOAMOCT BEATE _anearo. [lo Tos HAYA HHTTepBATET Ha RosMpae MOXe 1a GBae CExpaTeH M0 4 vaca. KopexTHaTa o3a 3a BCeKH OTAEAEH NAUHEHT € TASH, KORTO KOHTPaHpA GonkaTa H Ce NoHacs AOBpe npes UeTHA epHoa wa AosHpanie, Tip no-ronsmara sacr or naunerT#Te He ce HaTara MpHmiarane Ha AHeBHa 1032, 10-BHCOKA OT 400 mg. Bonpexi Topa, 38 HAKOH NALEHTH MO>KE fa Ca HEOBXOAHME TO-BHCOKH 2O3H. Tipa maunerrmn, Kowro nony'asar MpomykTH ¢ YABIDKEHO OCBOBOAKMABAHE Ha OKCHKOTON, OKCHKOAON Akrapic Moxe 1a ce HarionsBa 3a oBnanABale Ha BHiesaTia Gonka, HosaTa TpaGpa 2a ce KOpHTHPA B SABHCHMOCT OT HYAULHITE Ha MALINEHTa, HO O6ULOTO NPABHAO ¢, Ye eANOKpaTHaTa 03a TpAGEA na Sune 1/8 no 1/6 of aHesHaTa nosa Ha dopara ¢ yaBTxeHo OcBoGoxasane. IKHBOTOCTACABALUHTE siexapcToa He TpxGpa Ja ce Mpitarar fo-4ecTo OT BEATE Ha BeeKH 6 aca. 1H Ma neveMHETO H NpeycTanonal Tipena sanowsane na nevertue c OKcHKOMOH AKTaBMC ¢ MauHeHTa TpaGea Aa ce o6cbaN crpaTerin 32 JICHCHHE, BKIMOMHTEAHO NPOMBIOKHTENHOCT Ha NIeMEHHETO H UCM Ha Re4EHMETO, KAKTO H CXEMa 38 npeycTaHopsBave Ha ne¥eHHeTO, B CLOTBETCTBHE ¢ PLKOBOCTBATA 3a 7eHeHHe Ha Gorka. [lo BpeMe Ha sleveHMeTo TpxOBA a Ce OCBULECTBABA HECT KONTAKT MEATY EKAPR H MAUWeHTa, 32 Aa Ce OLEHH HYXaaTa OT NPOALUKNTEMHO sTeYEHHe, a Ce OGMHCTH MpeycTAHOBABANe H fa Ce KOPHTMPAT AO3HTe, ako ¢ HeoBxonHMo. KoraTo AaneH naUMeHT BeNe HAMA HYHUa OT JIeHeHHE ¢ OKCHKOROH, NPenopE4Ba ce nlocreneHHo HamanaBane Ha 10saTa, 3a 1a Ce npenOTapaTaT CHMATTOMH Ha OTHemane. TIpH munca Ha Toaxoasul KOHTpon Ha GonkaTa TpAGBA na ce OBMHCAM B&SMOXKHOCTTa 3a XHNepanresia, ToAepaNc H porpecs Ha OcHosHOTO saGonapante (Bx. TO¥KA 4.4). Tpommmsnreatoct na aesennero Oxcukonon He Tpa6aa aa ce mpHema nlo-nB1ro, oTKOMKOTO € HeoGxOnHMO. ‘Cneunaann nonynaune Heduampuina nonyaayua Oxcnkon0H Axtasie He ce npenopsusa sa ynorpeGa npn aeus roa |2-ronmuina Beapacr, Tei KATO GeonacHocrra H eukacHocTTa He ca YeraHOBeHM. Tauwenmu 6 cmapyecka eoapacm 3a kynupane Ha Goakara TpaGea Aa ce NpRAOKH Hali-HHcKaTa JOGA c BHUMATERHO THTpHPAHe, Tayuenrna c. 1 ra Me Tip taxipa rauverrrH Tpa6sa aa ce waNl07SBa KONCepBaTHBeH roAXoa NpH onpexeaaHe Ha HaNANHATa ‘nova. [penoppunTeavara Havana 103A 3a BEapACTHH NaUMeHTH TpAGBA 2a ce NOMIDKH C 50% (janpumep oGua aHepHa 03a oT 10 mg nepopanHo mpH HereKyBaH ¢ ONHOMAM nauneNTH) M AC.aTa nna Bcekn naueNT TpxOpa a Gee THTpupana 0 NOCTHraHe Ha anleKBATeH KOHTpoM Ha GonKaTa B cuoreTeTeHe ¢ KAMHNHATA KATHE, quenmu Puckonn naunelTi, KeTO MAUeHTH c HCKO TenecHO Tero HH 3aGaHeH MeTAGQTHSbM Ha eKapcTEEHH NPOAYKTH, MpBOHAYATHO TpAGEa Aa NpHeMaT nosoBHHATA OT NpenlopEyHTentia ‘3a BRAPACTHH, AKO 10 TOSH MOMENT HE cA AeKyBAHH ¢ ONHOHAH. Tlopaad Tosa Hali-HicKara npenopsunTemHa 23a, T.e. 5 mg, MOKe 1a He € NOAKOAALA KATO 3a. SE/H/12261001-00378028, 2 ‘Tunpuparieto na sosara Tpx6ea 1a Ce HSBHpLUBA 8 3ABHCHMOCT OT MILAMBHLAYANHATA KAHAN CUTYAUIKA H KATO ce ManosTIBa NO!XOAAUIA HANMYHA TeKapcTBeHA opNa. Hawn wa opmnorsenne 3a nepopasiHo nprnoxenne. OkcukozoH Axrasne tpx68a a ce npwara, KaTo ce Hanlonaea onpeertena IKCHaHa cxeMa Ha ZROsMpave, Ho Me no-HeCTO OT eAHH rat Ha BCeKH 4 0 6 saca. Kancyswte Morar ja ce npweMar cbc HM 6€3 XPaHA, C AOCTATS4HO KOMIHMECTBO TeHHOCT. Tlexapcrsenusr npoaykt He Tpa6na 28 Ce npweMa eAHOBPEMEHHO € AIKONOAHH HATHTKH. 43° Tpornponoxazanus © Cepexuyacrnnrentoct KEM AKTHBHOTO BeUECTBO HAH KEM tHAKOC OT NOMOWHHTE BeULecTBA, wxGpoenn 8 TouKa 6.1. ‘Texxa pecrparopxa slenpecis ¢ xHnOKCHN W/MTH XHTepKartta, ‘Texxe xponnuna OcTpykTHBHa GenoapoGua Gonect. Kop nysmonane. Texxa Gporxwanna acrwa. Tlapanirraven sneyc. Ocrsp Kopew, saGaneno Wanpassane Ha cromaxa. Oxcuxonon ne TpsGea ja ce HanOA3HA B CHTYAULAH, B KONTO MHpHOMCHHETO Ha ONHORAH & MporHsonoKasaHo. 4.4 Cneuuaann mperynpemaenus w npeanasin mepx npe ynorpeta BunManne ce #vcxea px MAUMeHTH 8 CTapHecka BBSPACT HAM HSTOWICHH GonHH, NPH MauHeHTH C TeRKo yepexnane Ha GenonpoGnara, 4epnonpobHara HAH GeOpeuna GyHKWWIA, MHKCEDEM, Xinormpeonmmses, Gonect Ha AAWCOH (HanDBOpeutia HemOCTATEMHOCT), ICHXO3A CE HHTOKCHKALHA (ianp. ankoxona), xuneprpoia va npocraraTa, a1peHOKOPTHKALtHa HEAOCTATb'HOCT @KOXOMMSEM, _YeraHoneta OnHOMAHa 3ABHCHMOCT, JEAMPHYM TPEMEHC, MAHKPEATHT, SAGOIABANE Ha ATLUAHTE TISTHULa, BEANATHTEAHM NpeBHH 3A60nABAHHA, AITEMHH HIM YPETPAHM KOAMKH, XHTOTOHNA, XMNOBONEMHA, CKCTORHHA € NOBHUNCHO HHTpAkPaHHAAMO HaATAHE KATO HapAnABAHe Na raaBaTa, LUNPKyaTOPHM HapyUICHHMA, NHTENCHA HLTH CKNOMHOCT KYM FBpYOBE H MPH NaUMeNTH, MPpHEMauLK MAO-nnxn6uropi. ‘Xupyprnsin. murrepsenun ‘OxcukonoH# TpaGsa Ja ce H3TI073BA ¢ NOBHIWEHO BHHMAHHe B NpegonepaTHBHHA NepHoA H Mpes: spate 12-24 waca cen onepaues. Kakro acH'ki onHOnIHM 7ekapcTBeHH NpoayKTH, TaKA H eKapeTBeHH MPORYKTH, CuIMEPAKaLLYE ‘oKcHKOION TpAGBA 1a ce NpHIAraT ¢ NOBHILEHO BHHMANHE c/eD ONepaTHBNA KOPeMHA HHTEpBEHUM, “Toil KATO € HBBECTHO, He ONMOMAHTE HapyulasaT MoTHAHTeTa Ha vepagTa H He TPAGBA sa ce HOTIOMIBAT DOKaTO seKaPAT He Ce YBEPH B HOPMATHOTO GyHKUMONMpaHe Ha NepBaTa. Mepnonpo6rio yapensnanie TlaunenTa ¢ Teaxxo seproapo6no yepexaane TpA6ea 2a GoaaT BHNMaTEZTHO HaBTORABANH, Pecnuparopiia aenpecus u nloTHcKaHie Ha cepaesiata OYHKWH Pecnuparopria senpechs e Hail-sHauMMHST PHCK, CBEPIAH c ynoTpeGaTa Ha ONHOMAH Me No-BepORTHO sna ce Ha6nloaana npH nayHeHTH B CTapsecka BLapACT HAM HaTOUIENH GonuH, PecnHpaTopHo ZENPCCHBHART e”peKT Ha OKCHKONOH MORE 118 NOBENE AO NOBHWENH KONLEHTPALAH Ha Bure} "AHOKCHA 6 KPbBTa M chOTBETHO B epeBpocrihnaniaTa TeuHocT. [Ip npeapasnonoxeHH nauyg onvionavre Morar 2a mpeawaBHKaT cHLIKO NOHiGKaBaHE Ha KPEBHOTO HaNATaHe, 'SEIH/1226/001-0030N028 res W110 BDEME Ha Chi ‘OnmonauTe Morar 2a NpHNMHUTT NWXETENHH HapylEHHA NO BpeMe Ha CBH, BKIIONATEAHO uerrpana conta antes (LICA) H xHnoKcemna no apeme Ha cbH. Ynotpebara Ha onOHaH nosHaBa pica or LICA no nosoxascHM HaYnH. Mpa nauneHTH, KoHTO B MomertTa crpaaar or LICA, owHcseTe Hanansnane Ha OGuATA AoA OMHOMIH. Puck or conatt aro Ge1t30; 1H NoACoHn ‘exaperpa Ennospemestiara ynorpeGa na OxcuKo70H AKTABHC H ceaTHBHM AeKapeTBa KaTo GeHIOAWA3enHHH a1 nogo6nw na Tax jeKapeTsa Moke sa NoBEne NO CenaLHAR, PecrMpaToptia ZenpecHE, KoMA H cwnpr. Tlopan Te3n pHckone eHonpemeHHoro nPeANHCBANE ¢ TeIH CenaTHBHH JeKapeTsa TpaGBa Aa ce 3aMla3H 38 NAUMEHTH, MPH KOHTO HE ca BAMORHH ATTePHATHBHH BEIMO:KHOCTH 38 e4eHHE, ‘Axo ce s3ema peulenne 3a npeannceane Ha OKcHKOAOH AkTaBHC eLHOBPEMeHHO Cb¢ CeaTHRHA sekapcTsa, TpxGsa Aa ce Hanon3ea Hali-HUcKaTa ebeKTMBHA 2038 M NPOBITAHTENMHOCTTA Ha neveHHeTo TpaGBa J1a Gaile BLSMOAHO Haii-KpaTKa. Tlauwenrture tpa6sa aa Gwsiar BHHMaTENHO MIPOCACAABANH 3a MpHSHAMLH H CHMTITOMH Ha pecnaparopxa aenpecna # ceampane, [lo TasH npHsitia ce mpenopBYea HAacTosTeNHo NaUMeHTHTE H Tpwxemire ce 3a TAX a GhilaT 9aO3HATH C TESH CHMITTOMH (BK. TONKA 4.5), 1H neKay Tlonocumoct w sasncnmoct Tlausesrrst more sia pasbiie NOHOCHMOCT KM /1ekapCTBEHHM MpOAyKT NPH NpOWHKHTEMIHA -ynorpe6a, KoeTo BoAH 20 NocTeneHHO HanloMsBaHe Ha NO-BHCOKH 1O3H 3a oBNaaRBAHE Ha GonkaTa Xponuumara ynorpe6a a TO3H NpOAYKT Moke sla AOBeAe AO dusHHecka saBHcHMoCT. CiieA PAIKO Inpexparasate Ha AeveniMeTo Morar sa ce HaGmOABAT CHMITTOMM Ha OTHEMAHE. AKO Bee He © neoBxoaHMO NpowexaaHe Ha Tepanns ¢ OXCHKONOH Ce NPenopEYBa NOCTENeHHO NOMFOKABAHE Ha sMesHava 2008, 38 1a ce waGerHe Nossa Ha a€cTHHeHTeH cHHApoM. CHMITTOMMTe Ha OTHEMAHE MoraT sia BKVOURAT NposseaHe, MHIPHATa, TaKPHNALIKR, PHHOPEs, TPeMop, XHnepxHaposa, GestoKoHicTBO, |EKUTAMMS, KOHBYNCHH H GEICBHHE. ‘Muro patko, ocoBeH0 Np BHCOKH 203K, MOKE a HACTBNM XHNepANresHA, KOATO He PearHpa Ha NO- HATATBUIHOTO YBemMMeHHE Ha LOSMpoBKaTA Ha OKCHKOAOK. Moke Aa ce Hao‘ NOHMDKABAHE Ha OvaTa Ha OKCHKOJOH WIM NIPEMMHABaHe Ha pyr aTTepHATHBCH ONHOKA. ier, 10-ce Ha. oH (snovi # ‘Monte a ce paspiiat ToneparTiiocT M GbyaHYeCKA H/T TICHXHYHa 3ABHCHMOCT pH MHOTOKPaTHO pHoxeHHe Ha ONHOHIH, KATO OKCHKOZOH. ‘Muoroxpatvara ynorpe6a Ha OxcHkon0H AkTaBHC MOxe a nOBesle 20 pascrpolicrso, AuDxALNO ce a ynorpe6ara 1a onHonan (Opioid Use Disorder, OUD). Mo-Bucoka ao3a 4 no-abnre NpOMMMKHTEMHOCT Ha NeYeHHETO ¢ ONHONT MOXe Aa yBenHuaT pHcka OT passwTHe Ha OUD. Snoynorpebara Han yMAULIeHaTa HenpasHana ynoTpeGa Ha OKCHKOROH AKTABHe MoxKe Jia AOBEME 0 nnpegoanpane Winn ewepr. Pucker or passurue Ha OUD ce ysennasa npn nauwerTH ANH Ha chania aviamniesa (Ha pomirenn wm Gpata/cectpn) 3a pascrpolicrao, mbsoxato ce Ha ynorpebaTa Ha newecTBa (skatousTenHo wOyNOTpeba C AIKOXON), MPH MAUEHTH, MOHACTORLIEM HBTIOMTSBALI TOTIOHEBH MpOAYKTH, HAH TPH MauUMeHTH C ANMHA aHaMeie3a 3a APYTH NCHXHYHH pascTpolicrea (HANp. TekKa AENPECHA, TPEBOOKHOCT H HINOCTHH pascTpoticrs Tipe sanopane Ha nevenne ¢ OxcHKoaoH AKTaBHC H No BpeMe Ha aeweHHeTO c nauneNTa TPAGEA za Obnat OBebAEHH UesMTe Ha NeveHHETO H cxeMa 3a NpeycTaHoBsBAHe (BX. ToUKa 4.2), Tpeaw HNO Bpeme Wa sleveHHeTO NawHeHTST TpaGsa Couto TaKa Aa Grae HAcpOpMUPaH 3a PHCKORETE H TIpHAHALITE va OUD. Maunenrst tpa6na 1a One noceeeTBaH Ja ce CARPE CBC CRON AeKAp MIpH NORA Ha Te3H pasa. Tip naunermere we ce wanickea Ha6moneNHE 44 NPHIHALM Ha NOREREHHE, CBEpsAHO ¢ NoBHYh norpe6Hoct oT jekapcTaoro (Hanp. TEPCeHe Ha HaMHH 3a NpemaespeMenHO NpHIOGMBAHE Hf neKapcrsoto). Tosa BKAIOMBA Npernes Ha CBMSTCTBAULM ONMOMAH H NCHXOAKTHBHH Ber ‘SEH/1226/001-0030A1028 Gerrsoanasenmian), pH nauenTH ¢ npHaHaiun H CHMITTOMH Ha OUD tpaGsa aa ce o6wHcaH KOHCYSITALIMA CLe CneyMANHCT No 3aBHeHMOCTH. ‘Baoynorpe6a Tlpx anoynorpeGa napesrrepanioro seHosHo HIDKEXTHpAHe Ha ChATBpAAHMETO Ha Kanicy;ara (ocoGeHO a Task) Moxe fla AoBese AO cepHOsHH, NoTeHIUANHO aTanKH CLOHTHA, Engoxpnnnn edexta ‘Onuonmre, xaTo Han. OKCHKOAOH XWIPOXTOPAL, MOFAT Aa NOBAMAST XHNOTAIAMO-XHNOMpHSHO- ampeHianunte WIM ronaguirre ocx. HakOw NPOMeHH, KOHTO MoraT aa ObnaT HaBONABAHH, BKMOUBAT OBHUIeHHe Ha CepyMHMA MpONAKTHH H MOHIoKeHMe Ha nujaaMeHHs KOpTH3OM M TeCTOCTEpOH. Kanineaiitre cnmmtoMt Morat a ca ¥apa3 Ha TesH XopMoHaHH MpOMeHH XenaroGwavapHH Hapyuienne Oxcuxozox Moxe 18 npesiriBiika HapywenHe Ha byMKuwesTa 4 cnasem Ha cebMakTepa Ha Oddi, KoeTo osnuana HitrpaGWiNapHoTO HANSTaHe H YBETHYaBA PHCKA OT MlORBa Ha CHMMFTOM OT CTpaNa Ha DeBMHHTe MSTHUIA H TIaHKpeaTHT. Tlopani TOBA OKCHKOZOH TpAGRa Ja ce NpHara C NOBHULEHO [BHMMAHHe MPH TauMeHTH ¢ NAHKpeaTHT M 3aGONABAHHA Ha ATBAHTE TETHUA. Anxoxon Kancyaure He 1paSsa na ce npleMar 2a¢qH0 ¢ ATKOXOAHM HANHTKM, Thll KATO ANKOXONHUTE HANHTKH YeWbar yapexxaaHeTO Ha BHMMAHHETO H YMeHASTa H MOTT fa yBeMMAT HeCTOTaTA Ha HExeZIaHMTE TekapcTBenH peakuni (Hamp. coMMONeHTHOCT, pecnuparopHa jenpechs) Teguarpyuea nonynauns ‘OxcukonoH He € npoy4BaH npx ea Ha Bkspacr mo 12 romHHH, Besonacnocrra u epukachocrTa or yMorpe6ava Ha KaNicysTe He ca AOKAIaHM, NOpaH KOeTO HaTIONSBAHETO My NH Aeua non 12- ToqHluna Btapact He ce npenops4Ba. Harpuii ‘Towa nexaperno ceamupxka no-waaxo or | mmol Harpuii (23 mg) wa xancy.na, T.e. MOXe la Ce KAKE, He MnpakraueckH He Cbibp-ka HaTpHi. 45 Buaumoseiicraue ¢ apyru sekaperaenu nposykTH WApyrH GopMH Ha BsaNMonelicTBMe BrsMoxkHo € nosmuleno noTHckaHe Ha KeHTpamara HepeHa CHCTEMa npH caHOBPeMeHna Tepaniia C aexapersa, KonTo sacarar LIHC (Hanp. apyrH oMHOMAH, cenaTHBH, XHMHOTHLM, AHTHAENpECAHTH, devornasuin, HesponenTiun). 3a MAO-nHxHGuTOpHTe € H3BECTHO, He BsaNMOReHCTBAT C HapKoTHMHHTe ananreTHUM M npemHsBuKBaT LHC BysGyna HAM AenpecHs c XHMep-KH XHNOTEHSMBHH pian (ek. TouKa 4.4), Oxciko0H TpaGea Ja ce Mphuiara c BHHMAHMe MpH NAUMeHTH AeKyBAH ¢ MAO-nexn6itTopH HAH Ha KoHTO ca npmaranH MAO-HHxnOMTOpH pes nocreaHMTe ABE CeAMHUM (ox TouKa 4.4), Envospemensara ynorpe6a Wa OnHOMaH Coc CeRATHBHH ACKAPCTBEHH NpOAVKTH, KATO Gersoanasennnm AIH NONOOHH Ha TAX AeKapCTBA NoBHullaBA PHCKa OT CeAALNA, PecnMpaTopHa nenpecus, Kowa # cMBpT nopazh aarTHpert IHC notackaw edexr. Josara u npoawoxtrenHoctTa Ha comsreraaulara ynorpeGa Tpa6sa 2a GeaaT orpannuenH (Bx. TONKA 4.4), Conprersaiioto mpHiorkeHie Ha OKCHKOON cbc CepoTOMHMHOBH cpeCTBA, KATO CeneKTHIBEH nurxn6xrTop wa oBpaTHoTo saxsautane Ha cepoToHana (SSRI) Haw ceneKTHBEH HIXHGHTOP Ha oSpaTHoTo saxsamlaiie a cepoToHMH-Hopaapenannn (SNRI) Moxke sta npeaMsaMKa cepoToHHHoBa ToRcHIHOCT. CHMMTTOMHTE Ha CepOTOHHHOBA TOKCHHOCT MO>Ke Aa BKAIOUBAT NPOMEHH B NCHXHUHHA cvatyc (Hanp. sbs6yne, xaoUMHaLI, KOMA), aBTOHOMHA HECTAOHAKOCT (Hanp. TAXHKapAwA, ;naGiiano KpuBHO Hanarave, xHmeprepMia), HepBHO-MyCKyAINH Hapywens (Hanp. xuneppeds SINnica Ha KOOPAMHALMA, PHTHHOCT) WHAM CTOMALIHO-YpeBHH CHMTTTOMH (HAN. FaneHe, ‘Amapua), OXCHKORON TpAEDA sa ce HSMOT3BA ¢ NOBMIEHO BHHMAHHE H Moxe 2a € HEOBN Hawanabavie Ha 2034Ta NpH NALMeHTH, KOKTO HotlomBaT Te3H AeKapeTBA, SEPHIT2261001-00370028 5 Anxoxomer mone 21a 3aCH1H bapMaKOAHHaMHMHHTE e:heKTH Ha OKCHKOOH: HEOGXORHMO € na ce wGnrea eaHospemenHara ynorpe6a. Anuxonnneprautre (Hamp. HeBponerTHU, aHTHXHCTaMHINH, AHTHEMCTHUM, AHTHMaPKHHCOHOBHL JeKapeTBeHM MPONYKTH) MOTaT 1a SACHAAT ANTHXONMHEPrMNHHTE HEKCNAHH PeAKLUH Ha OKCHKOAOH (karo KONCTHNALUAS, cyXoTa B YCTATA HIM MHKUIOHHM HapyLNeHHs). ‘Oxcion0n ce meTaGonnsupa ocHosHo ot CYP3A4 ¢ nomouira na CYP2D6. AkrupHoctute Ha Tes ba MeTaGOnHTHH MeTHWWA Morar 2a GeaaT MEXHOHpAHM HAH MHLAYUNpAHH OT past eaHOBpeMentio MpHnaraii# NeKapcTBa NAH XpanH. VirxnGirropure 1a CYP3A4 xato MakponHann aHTHGHoTHuM (Hanp. KTapHTpOMHUH, epHTPOMHUMH }cTenHTpOMMUKTH), aS00BH AHTHMHKOTHLM (HAN. KeTOKOHASOM, BOPHKOHASON, HTpakOHAsaN H nosakoHas0n), npoTeasHH MEXHGHTOpH (Hanp. GOUeNPEBMP, PHTOHABHP, HRAHHABH, HeNbHHABHD H CaxsHasHp), UAMETILIAH H COK OT rpelinbpyT, MOraT 2a NOBCAAT 10 HAMARCH KIKPBHC Ha OKCHKORON, KOETO MOKE 1a NPHYMHH NOBHUIABAHE HA MIASMEHHTE KOHLICHTPALMH Ha OKCHKOAOH. To -Ta3M MPHYHHa Mowe 2a Ce HATOAKH ChOTBETHA KOPEKUMA Ha 203ATA Ha OKCHKOOH. Tlo-nony ca name HaKOH KONKpeTHH NpHMEpH: © Hrpaxonaaon, mouten uixH6uTop Ha CYP3A4, npunarax no 200 mg nepopasHo 8 Npomboxenwe Ha ner aNH, nosmuasa AUC Ha nepopaniins oKcHKonON. CpenHo, crojiKocrra wa AUC € np6ansienno 2.4 mstu no-sicoxa (aManason 1,5 -3.4). © Bopakonason, winxn6irrop na CYP3A4, npxnarai no 200 mg asa msTH AHeBHO B npomWDKEHME a 4eTape ain (400 mg kato mopeHTe aBe no3H), noBisuaBa AUC Ha nepopasina OKCHKOZON. Cpenno, crofnocrra na AUC e npu6nisntento 3.6 meth no-BHcoxa (ananasoH 2,7 -6,6), © Teavrrpomaun, nixH6HTop Ha CYP3A4, npunaran no 800 mg nepopanio B npomBaKEHHE Ha eTHpH ani, nosiitiasa AUC Ha nepopania oxcuxonoH, Cpeato, cro#Hoctra Ha AUC € npuGaus#renso 1,8 mvH no-excoxa (aHanasoH 1,3 -2,3). © Cok or rpeiindpyr, snmxnGirrop na CYP3A4, npazarans no 200 ml tp msTH aneBHo NpomBIMkeHHe Ha eT AHH, NoBMUIaBA cTofHocTTa Ha AUC Ha nepopaatina OKCHKOTOH, Cpeano, ctoiinocrra aa AUC ¢ npuGawstrento 1,7 meta no-BHcoKa (ananasoH 1,1 -2,1)- iiayxropate na CYP3A4 Karo Hanpumep pucbanrmun, KapGamasemit, eHHTOHE HBT KatsTapnon MoraT na HEUIyLMpaT MeTaGOTHSMa Ha OKCHKOZON 4 a 1OBeqaT 10 NOBHitIaBaHe KAMPBHHCA Ha OKCHKOIOH, KOETO MOE 2a NPHMMITH HaMaAnABAHE MasMeHHTE KONLEHTPAWHH Ha OKCHKOION. Mone aa ce Hato>Kn osara Ha OKCHKOOH Aa ce KOpHTMpa cRoTRETHO. Tlo-nony ca aanenn HakoH KoHKpeTHH npHMEpH: © 2Kxorrusr xasrrapnon, muzyxtop na CYP3A4, npHnaran 8 21038 oT 300 mg TpH MBTH ZHeBHO B NpomurxeHne Ha neTHaneceT AHH, NoHWOKaBA cTofiNocTTa Ha AUC Ha nepopaniis OKCHKORON. Cpeano, ctoiinoctra na AUC e npbansirrento ¢ 50% no-nlicka (o6xBat 37 -57%). © Paibannaun, witayxrop Ha CYP3A4, npxtaran 032 oT 600 mg BemHBH AHEBHO B TpomuMKeHHe Ha CeneM sUMH, TOHIEKaBA CTOHHOCTTa Ha Nepopaniina oKCHKOAON. CpeaHo, cTofinocrra wa AUC € ¢ 86% no-HeKa. Jlexapersa, KoHTO MHXHGHpaT akTHBHocTTa Ha CYP2D6, KaTo napoKceTHH H XHHNIUH, Morar 2a AoBenAT 10 HaMaTABAHE KANPiHea Ha OKCHKOZOH, KOeTO Moke fa NPeAWSBNKA NOBHUIABAHE Ha mia3MeHHTe KOHUeHTPAUHH Ha OKeHKOAON. He ¢ wapecren ecpexta Ha apyritte Ha0eHSHMMH HAXHOMTOpH BEPXY MeTaGamHSMa Ha OKcHKORO} Heo6xonHMo e sa ce B2eMaT Nox BUKMauMe BLaMOKHIHTe BaaMMozelicTans. [loTeHIUMaAi OKCHKOROH BEPKY tUHTOXpOM PASO extsHMH He € NpOYHBAH in vitro HAH in vivo. SSE/H/1226/001-0031A028 Tipn camospemenHo npivloxkeHHe Ha KYNapHHOBM AHTHKOaryZaNTH C OKCHKODOH xHAPOXTOpHA kancy.1M ca HaGaNO]AKAHM KIKHHYNO HASHMI MPOMEHH B MEXKTyHApORHOTO HOPMATHSHpAHO otnoienne (INR) # 8 aiseTe nocoKH. 46 Depruauter, Cpemennoct w Kupmene Ynorpe6ara Ha TosH neKapcTecH npoaykT TpAOBa No BRIMOAHOCT na ce HAGATBA MPH NAUMENTKH, KouTO ca GpeMennit HAM KEPMAT. Bpementocr Taunrrre 32 ynorpeGara wa oKcHKo0H Mp 6pemeHHH wKeHH ca orpaHieHH. JeuaTa, poneHH oF Maliki, KOHTO ca NpHEMAIH ONHOMAK Nes NocneaHHTe 3 no 4 cenNMUK MpenH paxiaHeTo, TpA6BA na waar naGmozasani 2a nossa Ha pecnpatopHa nenpecus. BesMoxHo ¢ fa ce Ha6monaBaT ‘CHMITTOMH Ha OTHEMaHH PH HOBOpOREHH OT MaliKH, KONTO NPOBEAAT NeHeHHE C OKCHKONON. ‘OkcHkoa0H npemiiiasa npes nauesrara. FIpH mpoy'paHiTa ¢ OKCHKONON BEPXY 2KHBOTHH He CE {YeTaHOBAEAT TepaToreHHH HK EMGPHOTOKCHYHH e*peKTH. OKCHKOOH TpAGBA ia Ce HSNO.TSBA MO BpeMe Ha 6peMeHHOCT caMo ako NloNATa HANBHUIABA BLIMOXHITE PHCKOBE 30 NHNOsI HAM HoBoponeHoTo. Kepmene ‘OkcHkon0H npemHHaBa B KBPMaTa H MOXE a NPHAMHM pecrHpaTopHa AENpecHA NpH HoBOpOTEHOTO. Tlo TasH mpH4nHa OKcHKOIOH He TpABBa 2a ce HanOTIBA OT KEPMELIH MaiiKH. 4.7 Edexra supxy cnocoSnocrra 3a mogupane n paGora ¢ maura Oxcnkonon Mome 1a Hapywin cnocoBrocrTa 3a wodupante # paGora c aunt (sx. TOHKa 4.8). Tipa yreppacta cra6wina Tepanna He ce Hariara o6uia sa6pava 3a ynpasncsme Ha npeso3Ho cpencrao, Jlexysauust nexap TpaGsa aa NpeueHH MHAMBHAYAAHO BCRKA KONKPeTHa CHTYaLU. 48 Hexeaann sexapersenm peaxuun Penoe na npodana sa Gesonachoct OxcHxon0H Moxke 2a npeaHsBHKa pecrparopHa aenpecus, MHosa, GpoHXHaNHH cnasMH H cnasMM Ha rnakara MycKysaTypa H Mowe a NOTHCHE KAULINMHHE pedreKc. Cone Mtn Bs Tocouentre kaTeropii 3a ¥ecToTa wanonspaT cneaHaTa KOHBeHUHA: MHOrO HecTH (21/10), HeCTH 21/100 20 <1/10); wesecrH (1/1 000 20 <1/100); peak (21/10 000 0 K06a, 2. Ornenere esa GnncTepxa KaeTka no nepdopypaniTe AHHH 3. BHHMaTenHo oTAeneTe NOATOKKaTa, 3a a OTBOPHTE A>KOba, 7. TIPHTEXKATE.1 HA PA3PEUIEHHETO 3A YIIOTPEBA Teva BV. Swensweg 5 2031 GA Haarlem Huaepnannna 8, HOMEPHA PA3PEINIEHHETO 3A YNOTPEBA Oxcukoaon Axrasnc 10 mg raspam xancyau - per. No 20130045 Oxcnkozon Axrapnc 20 mg Taepan xancynn - per. Ne 20130046 9. ATA HA ITBPBO PA3PELIABAHE/HOJHOBABAHE HA PA3PELIEHHETO 3A, YMOTPEBA Alara va mpso paspeurasane: 17.01.2013 r. ‘Dara wa nocneano noaHosssave: 19.09.2018 r. 10, ATA HA AKTYASM3HPAHE HA TEKCTA 24.01.2024 ‘SEMH/1226/001-003/A/028 2

You might also like